A new study shows that people vaccinated with messenger RNA (mRNA) vaccines who then contract COVID-19 are likely to have a lower viral load, milder symptoms, and a quicker recovery rate than their unvaccinated counterparts.
The study, published in the New England Journal of Medicine on June 30, tracked 3,975 individuals to examine the effectiveness of two mRNA vaccines—the one by Moderna, and the one by Pfizer-BioNTech. Researchers sought to gauge the performance of the two-dose vaccines in preventing infection with the CCP (Chinese Communist Party) virus, which causes the disease COVID-19, and in reducing the impact of the illness on those who did become infected.
